Keywords: basf, sees, profits, collapse, earnings, hit, vitamin
BASF sees profits collapse as earnings are hit by vitamin price-fixing
Article | 06 August 1999
BASF of Germany has announced a slide in second-quarter operating profitof 41.7% to 421 million euros ($450.3 million), as sales fell 1.1% to 7.23 billion ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Athera and Boehringer Ingelheim enter option agreement on a novel therapy for atherosclerosis
- US Supreme Court says patent settlement can "sometimes" be illegal
- Actavis and Kissei file law suits against Sandoz and Hetero over Rapaflo patent
